Calliditas Therapeutics AB (publ) (CALT) Short Interest Ratio & Short Volume $40.00 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Calliditas Therapeutics AB (publ) Short Interest DataCalliditas Therapeutics AB (publ) (CALT) has a short interest of 3,500 shares. This marks a -60.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 10,339 shares to cover all short positions.Current Short Interest3,500 sharesPrevious Short Interest8,900 sharesChange Vs. Previous Month-60.67%Dollar Volume Sold Short$140,420.00Short Interest Ratio0.4 Days to CoverLast Record DateAugust 31, 2024Outstanding Shares29,790,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume0 sharesAverage Trading Volume10,339 sharesToday's Volume Vs. Average0% Short Selling Calliditas Therapeutics AB (publ)? Sign up to receive the latest short interest report for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCALT Short Interest Over TimeCALT Days to Cover Over TimeCALT Percentage of Float Shorted Over Time Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Calliditas Therapeutics AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/20243,500 shares $140,420.00 -60.7%N/A0.4 $40.12 8/15/20248,900 shares $346,744.00 +39.1%N/A0.6 $38.96 7/31/20246,400 shares $246,080.00 -23.8%N/A0.5 $38.45 7/15/20248,400 shares $325,248.00 -9.7%N/A0.6 $38.72 6/30/20249,300 shares $362,607.00 +13.4%N/A0.7 $38.99 6/15/20248,200 shares $317,914.00 No ChangeN/A0.6 $38.77 Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 5/31/20248,200 shares $327,918.00 -16.3%N/A0.7 $39.99 5/15/20249,800 shares $216,940.64 +12.6%N/A1.8 $22.14 4/30/20248,700 shares $168,867.00 +22.5%N/A1.4 $19.41 4/15/20247,100 shares $134,545.00 +121.9%N/A1 $18.95 3/31/20243,200 shares $67,232.00 -56.2%N/A0.4 $21.01 3/15/20247,300 shares $163,958.00 +15.9%N/A0.5 $22.46 2/29/20246,300 shares $134,312.85 +37.0%N/A0.4 $21.32 2/15/20244,600 shares $94,668.00 -20.7%N/A0.3 $20.58 1/31/20245,800 shares $132,588.00 No ChangeN/A0.4 $22.86 1/15/20245,800 shares $145,000.00 -43.1%N/A0.4 $25.00 12/31/202310,200 shares $262,588.80 +20.0%N/A0.6 $25.74 12/15/20238,500 shares $187,765.00 -29.2%N/A0.6 $22.09 11/30/202312,000 shares $208,200.00 +26.3%N/A1.1 $17.35 11/15/20239,500 shares $161,215.00 +93.9%N/A0.9 $16.97 10/31/20234,900 shares $79,870.00 +63.3%N/A0.5 $16.30 10/15/20233,000 shares $52,050.00 -21.1%N/A0.3 $17.35 9/30/20233,800 shares $69,388.00 +40.7%N/A0.4 $18.26 9/15/20232,700 shares $43,104.42 -34.2%N/A0.3 $15.96 8/31/20234,100 shares $72,652.00 -48.1%N/A0.6 $17.72 8/15/20237,900 shares $152,707.00 +315.8%N/A1.1 $19.33 7/31/20231,900 shares $37,050.00 -24.0%N/A0.3 $19.50 7/15/20232,500 shares $40,125.00 +4.2%N/A0.4 $16.05 6/30/20232,400 shares $37,680.00 -51.0%N/A0.4 $15.70 6/15/20234,900 shares $89,363.75 -41.7%N/A0.8 $18.24 5/31/20238,400 shares $143,304.00 +47.4%N/A0.8 $17.06 5/15/20235,700 shares $145,350.00 +128.0%N/A0.5 $25.50 4/30/20232,500 shares $58,350.00 -77.3%N/A0.2 $23.34 4/15/202311,000 shares $272,250.00 -16.0%N/A0.8 $24.75 3/31/202313,100 shares $314,007.00 -42.3%N/A0.9 $23.97 3/15/202322,700 shares $572,948.00 +58.7%N/A1.6 $25.24 2/28/202314,300 shares $264,693.00 +346.9%N/A1.4 $18.51 2/15/20233,200 shares $57,472.00 +10.3%N/A0.3 $17.96 1/31/20232,900 shares $55,680.00 -52.5%N/A0.3 $19.20 1/15/20236,100 shares $120,780.00 -38.4%N/A0.6 $19.80Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 12/30/20229,900 shares $168,300.00 +67.8%N/A0.9 $17.00 12/15/20225,900 shares $115,616.40 -38.5%N/A0.5 $19.60 11/30/20229,600 shares $174,432.00 +37.1%N/A0.8 $18.17 11/15/20227,000 shares $115,500.00 +25.0%N/A0.7 $16.50 10/31/20225,600 shares $83,440.00 +60.0%N/A0.6 $14.90 10/15/20223,500 shares $54,600.00 -59.3%N/A0.4 $15.60 9/30/20228,600 shares $130,428.46 +230.8%N/A1.4 $15.17 9/15/20222,600 shares $41,106.00 -27.8%N/A0.5 $15.81 8/31/20223,600 shares $59,400.00 -49.3%N/A0.8 $16.50 8/15/20227,100 shares $153,005.00 +4.4%N/A1.4 $21.55 7/31/20226,800 shares $126,820.00 -9.3%N/A1 $18.65 7/15/20227,500 shares $135,900.00 -22.7%N/A1.1 $18.12 6/30/20229,700 shares $172,175.00 -29.2%N/A1.3 $17.75 6/15/202213,700 shares $238,838.95 -19.9%N/A1.7 $17.43 5/31/202217,100 shares $305,235.00 -59.6%N/A1.8 $17.85 5/15/202242,300 shares $599,391.00 -34.0%N/A3.6 $14.17 4/30/202264,100 shares $942,911.00 -6.6%N/A5.7 $14.71 4/15/202268,600 shares $1.26 million -6.7%N/A4.1 $18.31 3/31/202273,500 shares $1.41 million -3.4%N/A3.4 $19.14 3/15/202276,100 shares $1.27 million +4.3%N/A2.1 $16.74 2/28/202273,000 shares $1.44 million +22.1%N/A0.4 $19.75 2/15/202259,800 shares $1.31 million -10.3%N/A0.3 $21.85 1/31/202266,700 shares $1.41 million -25.0%N/A0.4 $21.21 1/15/202288,900 shares $2.06 million +51.2%N/A0.5 $23.17 12/31/202158,800 shares $1.46 million -41.7%N/A0.3 $24.76 12/15/2021100,800 shares $1.88 million +94.2%N/A0.6 $18.64 11/30/202151,900 shares $954,441.00 +25.7%N/A1.4 $18.39 11/15/202141,300 shares $707,882.00 -29.3%N/A1.1 $17.14 10/29/202158,400 shares $953,088.00 +11.9%N/A1.4 $16.32 10/15/202152,200 shares $1.16 million +26.1%N/A1.6 $22.18 9/30/202141,400 shares $895,068.00 -56.0%N/A1.3 $21.62 9/15/202194,000 shares $2.13 million +67.0%N/A3 $22.71 8/31/202156,300 shares $1.59 million +50.1%N/A2.3 $28.18 8/13/202137,500 shares $1.13 million -18.7%N/A2 $30.15 7/30/202146,100 shares $1.34 million -3.0%0.2%3.5 $29.05 7/15/202147,500 shares $1.39 million +5.1%0.2%1.8 $29.20 6/30/202145,200 shares $1.33 million -12.2%0.2%1.4 $29.45 6/15/202151,500 shares $1.56 million -8.5%0.2%1.4 $30.39 5/28/202156,300 shares $1.67 million -0.5%0.2%1.5 $29.60 5/14/202156,600 shares $1.53 million +55.9%0.2%1.5 $27.12 4/30/202136,300 shares $1.08 million +58.5%0.2%0.9 $29.64 4/15/202122,900 shares $617,155.00 No Change0.1%0.6 $26.95 3/31/202122,900 shares $628,834.00 -4.6%0.1%0.7 $27.46 3/15/202124,000 shares $718,560.00 +211.7%0.1%1 $29.94 2/26/20217,700 shares $222,068.00 +102.6%0.0%0.3 $28.84 2/12/20213,800 shares $121,828.00 -24.0%0.0%0.2 $32.06 1/29/20215,000 shares $140,700.00 +11.1%0.0%0.1 $28.14 1/15/20214,500 shares $140,085.00 No Change0.0%0.1 $31.13 CALT Short Interest - Frequently Asked Questions What is Calliditas Therapeutics AB (publ)'s current short interest? Short interest is the volume of Calliditas Therapeutics AB (publ) shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 3,500 shares of CALT short. Learn More on Calliditas Therapeutics AB (publ)'s current short interest. Is Calliditas Therapeutics AB (publ)'s short interest increasing or decreasing? Calliditas Therapeutics AB (publ) saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 3,500 shares, a decline of 60.7% from the previous total of 8,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Calliditas Therapeutics AB (publ)'s short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Calliditas Therapeutics AB (publ): Travere Therapeutics, Inc. (10.24%), Omeros Co. (21.64%), Enanta Pharmaceuticals, Inc. (17.46%), Biohaven Ltd. (9.05%), Crinetics Pharmaceuticals, Inc. (7.48%), BridgeBio Pharma, Inc. (11.71%), Ultragenyx Pharmaceutical Inc. (3.44%), Immunovant, Inc. (21.05%), Organon & Co. (5.51%), Rhythm Pharmaceuticals, Inc. (13.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks. What does it mean to sell short Calliditas Therapeutics AB (publ) stock? Short selling CALT is an investing strategy that aims to generate trading profit from Calliditas Therapeutics AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calliditas Therapeutics AB (publ)? A short squeeze for Calliditas Therapeutics AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CALT, which in turn drives the price of the stock up even further. How often is Calliditas Therapeutics AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CALT, twice per month. The most recent reporting period available is August, 31 2024. More Short Interest Resources from MarketBeat Related Companies TVTX Short Squeeze OMER Short Squeeze ENTA Short Squeeze BHVN Short Squeeze CRNX Short Squeeze BBIO Short Squeeze RARE Short Squeeze IMVT Short Squeeze OGN Short Squeeze RYTM Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CALT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
